Cantabio Pharmaceuticals Inc (CTBO)
1.01
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Cantabio Pharmaceuticals Cash from Operations (TTM): -0.7984M for Dec. 31, 2018
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2018 | -0.7984M |
September 30, 2018 | -0.6932M |
June 30, 2018 | -0.6583M |
March 31, 2018 | -0.6233M |
December 31, 2017 | -0.7794M |
September 30, 2017 | -0.737M |
June 30, 2017 | -0.8872M |
March 31, 2017 | -0.9731M |
December 31, 2016 | -0.8108M |
September 30, 2016 | -0.8909M |
June 30, 2016 | -0.7586M |
March 31, 2016 | -0.5647M |
Date | Value |
---|---|
December 31, 2015 | -0.3834M |
September 30, 2015 | -0.1823M |
June 30, 2015 | -0.0364M |
March 31, 2015 | 0.0002M |
December 31, 2014 | -0.0034M |
September 30, 2014 | -0.018M |
June 30, 2014 | -0.0354M |
March 31, 2014 | -0.051M |
December 31, 2013 | -0.0573M |
September 30, 2013 | -0.0553M |
June 30, 2013 | -0.04M |
March 31, 2013 | -0.0263M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
Humanigen Inc | -64.32M |
Affymax Inc | -- |
RVL Pharmaceuticals PLC | -44.41M |
Scopus BioPharma Inc | -3.043M |
Statera BioPharma Inc | -12.09M |